F.A.Q.
Why participate in clinical trials?
- Although science is advancing, there are still no treatments for some diseases. Participating in clinical trials contributes to a greater cause, which is the development of new and known medications. For their part, researchers work diligently to find new treatments and improve certain medications. Part of the credit for medications that are currently available on the market goes to volunteers who participated in clinical trials.
Why participate in clinical trials at Algorithme Pharma?
- To contribute to a good cause – the development of medications.
- To increase the availability of generic medications, which are more affordable.
- Because you will be greeted by a competent, courteous and friendly medical staff in a very safe environment. The rigor of our 600 employees is demonstrated by the superior ethical and professional standards we always apply.
- To benefit from our new Phase I/IIa study clinic, where, among other features, semi-private rooms are available.
- Because you will enjoy the friendly atmosphere. Our volunteers are largely responsible for the pleasant atmosphere of our clinical trials.
- Because participating in a clinical trial allows you to have an assessment of your health.
- Because you will receive a financial compensation for your participation. This compensation usually varies between $700 and $4000 according to the study you complete.
What types of clinical trials are conducted by Algorithme Pharma?
- For over 12 years, Algorithme Pharma has been conducting Bioequivalence and Phase I/IIa clinical trials on healthy volunteers who wish to contribute to clinical research:
- Bioequivalence studies are a type of clinical research trials that compare two products, usually from different companies, that contain the same medication. This type of study generally shows that the generic (copy) formulation behaves in the same manner as the original product already on the market.
- Phases I and IIa studies contribute mainly to the development of new medications. Their purpose is to determine how new medications behave in different situations.
What is a compensatory indemnity?
- You will be compensated for your participation in the clinical trial. Volunteers who participate in a study receive between $700 and $4,000. The compensation depends on various factors, such as the time spent at the clinic, the number of follow-up visits and the type of study completed. To ensure the success of the study, your presence is required on all dates of the study.
Are meals served during the stay?
- Meals are part of the study. The staff present during the study will serve balanced meals.
Is there a risk of adverse effects?
- Although medications are administered with the greatest care, some volunteers may experience side effects, most of which are mild. Rest assured that throughout the study, our doctors and medical staff will be on site to provide the necessary care should you experience any such effects.
How do I know that Algorithme Pharma is a reliable company?
- Algorithme Pharma has been inspected by the following government agencies:
√ Health Canada's Therapeutic Products Directorate (TPD),
√ The U.S. Food and Drug Administration (FDA),
√ The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK,
√ The French Health Products Safety Agency (AFSSAPS),
√ The Austrian Agency for Health and Food Safety (AGES) in Austria,
√ The National Health Surveillance Agency Brazil (ANVISA) in Brazil.
- These government agencies have inspected the various Algorithme Pharma clinical operations and have validated the security, efficiency and quality of our services as required by their respective regulations.
Is your personal information protected at all times?
- Algorithme Pharma pays particular attention to personal information to ensure that it is kept completely confidential (secure). Access to this information is granted only to authorized Algorithme Pharma personnel, sponsors and regulatory agencies. Algorithme Pharma follows very rigorous personal information protection and safety policies and practices in accordance with the Personal Information Protection and Electronic Document Act (PIPEDA).
- Most of the information that we collect about you is gathered when you inquire about participating in one of our clinical trials. At that time, we ask only for information that we need to process your request, and that will help us present studies that may interest you and/or correspond to your profile. It is important for us to obtain your consent to collect, use and communicate your personal information. Based on the sensitivity of the personal information collected, your consent may be manifest, free, and enlightened, and must be given for specific purposes. Sometimes, you may be asked to give explicit consent. There are different types of explicit consent, like checking a box when you agree to receive communications, or signing an application form to show you accept its conditions of use and disclosure.
- For further details on this matter, we strongly encourage you to read our pamphlet that specifically refers to your personal information.
For more information about our clinical trials, please contact one of our
agents:
(514) 381-2546 (ALGO) or 1 888 758-6312 (toll free)
Follow us on Twitter and Facebook to find out about all on-going activities related to our clinical trials.